###begin article-title 0
Glutathione S-transferase M1 and T1 polymorphismsâ€¨###xml 17 25 <span type="species:ncbi:9606">patients</span>
in Arab glaucoma patients
###end article-title 0
###begin p 1
This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Purpose
###end title 2
###begin p 3
###xml 182 187 182 187 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTT1</italic>
###xml 192 197 192 197 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTM1</italic>
###xml 174 180 <span type="species:ncbi:9606">humans</span>
Glutathione S-transferases (GSTs) are a family of enzymes that inactivate xenobiotics and endogenous end products formed as secondary metabolites during oxidative stress. In humans, GSTT1 and GSTM1 deletion genotypes (T0M1, T1M0, and T0M0) are associated with a variety of pathologic processes including certain ophthalmologic diseases.
###end p 3
###begin title 4
Methods
###end title 4
###begin p 5
###xml 30 35 30 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTT1</italic>
###xml 40 45 40 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTM1</italic>
###xml 140 148 <span type="species:ncbi:9606">patients</span>
We compared the prevalence of GSTT1 and GSTM1 deletion genotypes, which were determined by multiplex polymerase chain reaction, in 107 Arab patients with glaucoma (49 with primary open-angle glaucoma, 29 with pseudoexfoliation glaucoma, and 29 with primary angle-closure glaucoma) to 120 age, sex, and ethnically matched controls.
###end p 5
###begin title 6
Results
###end title 6
###begin p 7
###xml 131 139 <span type="species:ncbi:9606">patients</span>
###xml 309 317 <span type="species:ncbi:9606">patients</span>
###xml 481 489 <span type="species:ncbi:9606">patients</span>
All three GST polymorphisms were significantly more common in the entire glaucoma group (p<0.0167) than in controls. However, when patients were stratified by glaucoma type, the deletion genotype, T0M0, was not particularly associated with any type of glaucoma tested. The T1MO genotype was more common among patients with each type of glaucoma than among controls whereas T0M1 genotype was more common among pseudoexfoliation glaucoma (PEG) and primary open-angle glaucoma (POAG) patients than controls.
###end p 7
###begin title 8
Conclusions
###end title 8
###begin p 9
###xml 77 82 77 82 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTT1</italic>
###xml 87 92 87 92 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTM1</italic>
The overall results indicate a possible variable association between various GSTT1 and GSTM1 genotypes and glaucoma in this population. Decreased GST function might interfere with the metabolism of oxidative intermediates and exacerbate the direct or indirect damaging effects of oxidative stress on the optic nerve. It is possible that these GST polymorphisms may be risk factors for glaucoma.
###end p 9
###begin title 10
Introduction
###end title 10
###begin p 11
###xml 128 129 128 129 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r1">1</xref>
###xml 319 320 319 320 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r2">2</xref>
###xml 360 361 360 361 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r3">3</xref>
###xml 401 402 401 402 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r4">4</xref>
###xml 485 486 485 486 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r3">3</xref>
###xml 487 488 487 488 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r5">5</xref>
###xml 489 490 489 490 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r6">6</xref>
###xml 64 70 <span type="species:ncbi:9606">humans</span>
Glaucoma is the most common optic neuropathic process affecting humans and the second most common cause of blindness worldwide [1]. It is a complex, heterogeneous disease with a multifactorial etiology including mechanical damage due to increased intraocular pressure (IOP), variable susceptibility of the optic nerve [2], mutations in specific nuclear genes [3], changes in the mitochondrial genome [4], and toxic effects and oxidative damage caused by reactive oxygen species (ROS) [3,5,6].
###end p 11
###begin p 12
###xml 344 345 344 345 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r7">7</xref>
###xml 456 457 456 457 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r8">8</xref>
The glutathione S-transferases (GSTs) are a family of enzymes consisting of numerous cytosolic, mitochondrial, and microsomal proteins capable of multiple reactions with endogenous and xenobiotic substrates. They catalyze the conjugation of reduced glutathione to electrophilic centers via the sulfhydryl group on a wide variety of substrates [7]. GSTs bind toxins, function as transport proteins, detoxify endogenous compounds such as peroxidized lipids [8], and inactivate endogenous end products formed as secondary metabolites during oxidative stress.
###end p 12
###begin p 13
###xml 267 272 267 272 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTT1</italic>
###xml 277 282 277 282 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTM1</italic>
###xml 622 623 622 623 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r9">9</xref>
###xml 624 626 624 626 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r11">11</xref>
###xml 720 722 720 722 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r12">12</xref>
###xml 757 759 757 759 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r13">13</xref>
###xml 3 9 <span type="species:ncbi:9606">humans</span>
In humans, GST enzymes are divided into five classes - alpha (A), mu (M), pi (P), theta (T) and zeta (Z) - with each class encompassing several genes and isoenzymes. Previous studies of allelic variants in these classes have identified two major polymorphisms of the GSTT1 and GSTM1 genes caused by a deletion in each gene. These deletions result in the virtual absence of enzyme activity, particularly in individuals with deletions in both genes (null genotype). The null genotype (T0M0) has been associated with altered risk of a variety of pathologies including cancer, cardiovascular disease, and respiratory disease [9-11]. GST polymorphisms have also been associated with ophthalmologic problems such as cataract [12] and senile macular degeneration [13].
###end p 13
###begin p 14
###xml 204 205 204 205 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r4">4</xref>
###xml 290 292 290 292 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r14">14</xref>
###xml 293 295 293 295 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r17">17</xref>
###xml 465 470 465 470 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTM1</italic>
###xml 475 480 475 480 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTT1</italic>
###xml 64 72 <span type="species:ncbi:9606">patients</span>
###xml 504 512 <span type="species:ncbi:9606">patients</span>
We recently reported evidence of mitochondrial abnormalities in patients with primary open-angle glaucoma (POAG), implying that an oxidative stress mechanism might contribute to the pathogenesis of POAG [4]. In fact, several studies have found GST polymorphisms to be risk factors in POAG [14-17]. Because of the role of GSTs in inactivating endogenous end products formed as secondary metabolites during oxidative stress, we decided to compare the distribution of GSTM1 and GSTT1 polymorphisms in Saudi patients with POAG, pseudoexfoliation glaucoma (PEG), and primary angle-closure glaucoma (PACG) to the distribution in matching healthy controls.
###end p 14
###begin title 15
Methods
###end title 15
###begin title 16
###xml 0 8 <span type="species:ncbi:9606">Patients</span>
Patients and controls
###end title 16
###begin p 17
###xml 196 197 196 197 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r4">4</xref>
###xml 198 200 198 200 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r18">18</xref>
###xml 201 203 201 203 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r19">19</xref>
###xml 24 32 <span type="species:ncbi:9606">patients</span>
###xml 210 218 <span type="species:ncbi:9606">patients</span>
###xml 535 543 <span type="species:ncbi:9606">Patients</span>
###xml 871 879 <span type="species:ncbi:9606">patients</span>
A total of 107 glaucoma patients (49 with POAG, 29 with PEG, and 29 with PACG) were enrolled in this study. The inclusion and exclusion criteria for each type of glaucoma were detailed elsewhere [4,18,19]. All patients were Saudi Arabs selected from the Glaucoma Clinic at King Khaled Eye Specialist Hospital (KKESH) after an examination by a glaucoma specialist (J.M.) and informed consent approved by the KKESH IRB. Records were reviewed, a general medical history was taken, and complete ophthalmologic examinations were performed. Patients had either Goldmann manual kinetic perimetry (Haag Streit AG, Koeniz-Berne, Switzerland), Humphrey automated white on white stimulus static perimetry (Humphrey Field Analyzer II, Humphrey Systems, Dublin, CA), or both. Optical coherence tomography was performed with the OCT3 Unit by Humphrey Systems (San Leandro, CA) on some patients. Fundus photos were obtained using a Zeiss FF 450 system and conventional film. This research followed the tenets of the Declaration of Helsinki. Family members were not evaluated clinically or genetically.
###end p 17
###begin p 18
Control subjects were blood donors at the King Faisal Specialist Hospital and Research Centre who represented the spectrum of Saudi Arabs and who reported no symptomatic, metabolic, genetic, or ocular disorder on an extensive questionnaire about family history, past medical problems, and current health.
###end p 18
###begin title 19
Sample collection and DNA extraction
###end title 19
###begin p 20
Peripheral blood (5 ml) was collected in EDTA tubes from all participating individuals after obtaining their written consent. DNA extraction was performed using the PURGENE DNA isolation kit from Gentra Systems (Minneapolis, MN), and the DNA was stored in aliquots at -20 degreesC until required.
###end p 20
###begin title 21
###xml 12 17 12 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTM1</italic>
###xml 22 27 22 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTT1</italic>
Analysis of GSTM1 and GSTT1 polymorphisms
###end title 21
###begin p 22
###xml 107 112 107 112 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTT1</italic>
###xml 167 172 167 172 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTT1</italic>
###xml 223 228 223 228 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTM1</italic>
###xml 287 292 287 292 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTM1</italic>
###xml 428 429 420 421 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1006 1011 984 989 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTT1</italic>
###xml 1027 1032 1005 1010 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTM1</italic>
This was performed by multiplex polymerase chain reaction (PCR) amplification using the following primers: GSTT1 forward primer 5 -TTC CTT ACT GGT CCT CAC ATC TC -3 ; GSTT1 reverse primer 5 -TCA CCG GAT CAT GGC CAG CA -3 ; GSTM1 forward primer 5 - GAA CTC CCT GAA AAG CTA AAG C -3 ; and GSTM1 reverse primer 5 - GTT GGG CTC AAA TAT ACG GTG G -3 . Each 25 microl PCR reaction contained 2.5 microl of 10X reaction buffer with MgCl2 (Amersham Pharmacia Biotech, Piscataway, NJ), 10 rhomol of each primer, 100 rhomol/microl each of deoxynucleoside triphosphates (deoxyATP, deoxyguanosine triphosphate, deoxycytidine triphosphate, and deoxythymidine triphosphate; Perkin-Elmer Corporation, Foster City, CA) in Tris-HCl buffer, 1 unit of HotStar Taq DNA polymerase (Amersham Pharmacia Biotech, Piscataway, NJ), and 100 ng genomic DNA template at annealing temperature of 58 degreesC for 40 cycles. The PCR products were visualized on a 2% agarose gel electrophoresis at 100 V for 50 min. Two bands of 459 bp for GSTT1 and 209 bp for GSTM1 were obtained for the T1M1 genotype. The T1M0 genotype showed one band of 459 bp, and the T0M1 genotype showed a band of 209 bp. For the T0M0 genotype (homozygous absence or deletion genotype is designated as null genotype), no bands were obtained and thus the use of beta-globin internal positive control was necessary to distinguish the null genotype from aborted PCR reactions.
###end p 22
###begin title 23
Statistical analysis
###end title 23
###begin p 24
###xml 221 222 221 222 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 183 191 <span type="species:ncbi:9606">patients</span>
Genotype frequencies, sex distribution, and smoking history were compared among the different glaucoma groups and the controls by the chi square test. The mean age comparison between patients and controls was analyzed by t-test. A two-tailed p value of less than 0.05 was considered statistically significant, and odds ratio with 95% confidence intervals were reported. The Bonferroni correction was used to adjust the significance level of a statistical test to protect against Type I errors when multiple comparisons are being made. All analyses were performed using SPSS v.13 statistical analysis software (SPSS Inc., Chicago, IL).
###end p 24
###begin title 25
Results
###end title 25
###begin p 26
###xml 122 123 122 123 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r4">4</xref>
###xml 124 126 124 126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r18">18</xref>
###xml 127 129 127 129 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r19">19</xref>
###xml 14 22 <span type="species:ncbi:9606">patients</span>
###xml 98 106 <span type="species:ncbi:9606">patients</span>
###xml 239 247 <span type="species:ncbi:9606">patients</span>
Most of these patients were included in previous reports of nuclear and mitochondrial genetics in patients with glaucoma [4,18,19]. The control group consisted of 120 individuals (78 males and 42 females, mean age 60.5 +/- 9.1 years). All patients and control subjects were of Saudi Arabian origin.
###end p 26
###begin p 27
###xml 0 7 0 7 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t1">Table 1</xref>
###xml 44 52 <span type="species:ncbi:9606">patients</span>
###xml 67 75 <span type="species:ncbi:9606">Patients</span>
Table 1 shows demographic data for glaucoma patients and controls. Patients and controls were not significantly different with respect to sex, age, and smoking status (p>0.0167); therefore, these variables were not evaluated further.
###end p 27
###begin title 28
Demographic data of the study groups.
###end title 28
###begin p 29
###xml 0 8 <span type="species:ncbi:9606">Patients</span>
Patients and controls were not significantly different with respect to sex, age and smoking status (p>0.0167).
###end p 29
###begin p 30
###xml 0 7 0 7 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t2">Table 2</xref>
###xml 63 71 <span type="species:ncbi:9606">patients</span>
###xml 171 179 <span type="species:ncbi:9606">patients</span>
Table 2 shows the GST genotype distribution among all glaucoma patients and controls. The frequency of all genotypes investigated was significantly greater among glaucoma patients than controls.
###end p 30
###begin title 31
Glutathione S-transferase genotypes and the risk of developing glaucoma.
###end title 31
###begin p 32
###xml 94 102 <span type="species:ncbi:9606">patients</span>
The frequency of all deletion genotypes investigated was significantly greater among glaucoma patients than controls (after Bonferroni correction, p-value < 0.0167 was considered statistically significant).
###end p 32
###begin p 33
###xml 78 85 78 85 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t3">Table 3</xref>
###xml 290 297 290 297 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t4">Table 4</xref>
###xml 482 489 482 489 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t5">Table 5</xref>
###xml 176 184 <span type="species:ncbi:9606">patients</span>
###xml 367 375 <span type="species:ncbi:9606">patients</span>
###xml 571 579 <span type="species:ncbi:9606">patients</span>
We also examined GST genotype distribution in all three variants of glaucoma. Table 3 shows that the frequency of the T1M0 and T0M1 genotypes was significantly greater in POAG patients than in controls (p=0.00001) while the frequency of the T0M0 null genotype was not significant (p=0.06). Table 4 shows that all deletion GST genotype frequencies were greater in PEG patients than in controls, except for the T0M0 null genotype, which fell slightly short of significance (p=0.021). Table 5 shows that the frequency of the T1M0 genotypes was significantly greater in PACG patients than in controls (p=0.0002) whereas T0M0 and T0M1 were not significant.
###end p 33
###begin title 34
Glutathione S-transferase genotypes and the risk of developing primary open-angle glaucoma.
###end title 34
###begin p 35
###xml 79 87 <span type="species:ncbi:9606">patients</span>
The frequency of the T1M0 and T0M1 genotypes was significantly greater in POAG patients than controls (p=0.00001), while the frequency of the T0M0 null genotype which was not significant (p=0.06). After Bonferroni correction, p-value < 0.0167 was considered statistically significant.
###end p 35
###begin title 36
Glutathione S-transferase genotypes and the risk of developing pseudoexfoliation glaucoma.
###end title 36
###begin p 37
###xml 58 66 <span type="species:ncbi:9606">patients</span>
All deletion GST genotype frequencies were greater in PEG patients than controls, except for the T0M0 null genotype, which fell slightly short of significance (p=0.021). After Bonferroni correction, p-value < 0.0167 was considered statistically significant.
###end p 37
###begin title 38
Glutathione S-transferase genotypes and the risk of developing primary angle-closure.
###end title 38
###begin p 39
###xml 69 77 <span type="species:ncbi:9606">patients</span>
The frequency of the T1M0 genotype was significantly greater in PACG patients than in controls (p=0.0002), whereas the prevalence of T0M0 and T0M1 genotypes were not statistically different from controls. After Bonferroni correction, p-value < 0.0167 was considered statistically significant.
###end p 39
###begin title 40
Discussion
###end title 40
###begin p 41
###xml 115 116 115 116 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r4">4</xref>
###xml 117 119 117 119 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r18">18</xref>
###xml 120 122 120 122 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r19">19</xref>
###xml 9 17 <span type="species:ncbi:9606">patients</span>
###xml 169 177 <span type="species:ncbi:9606">patients</span>
###xml 599 607 <span type="species:ncbi:9606">patients</span>
Glaucoma patients in this study met strict criteria for POAG, PEG, and PACG, which have been described previously [4,18,19]. Controls in this study were well matched to patients for age, sex, ethnicity, and smoking status. The T1M0 and the T0M1 genotypes were significantly more common in the entire glaucoma group and were almost all more common in each individual variant of glaucoma as well. The full deletion (T0M0 null genotype) was almost not associated with any particular type of glaucoma. We believe that this is the first study to quantify the prevalence of these polymorphisms among Arab patients with various types of glaucoma.
###end p 41
###begin p 42
###xml 65 70 65 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTT1</italic>
###xml 74 79 74 79 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTM1</italic>
###xml 117 119 117 119 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r14">14</xref>
###xml 120 122 120 122 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r17">17</xref>
###xml 135 137 135 137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r15">15</xref>
###xml 153 155 153 155 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r16">16</xref>
###xml 271 273 271 273 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r20">20</xref>
###xml 579 580 579 580 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r9">9</xref>
###xml 658 660 658 660 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r17">17</xref>
###xml 1067 1069 1067 1069 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r21">21</xref>
###xml 1212 1220 <span type="species:ncbi:9606">patients</span>
Our results are in concordance with previous studies associating GSTT1 or GSTM1 gene deletions with POAG in Turkish [14,17], Estonian [15], and Italian [16] populations, although one study reported no association between these genotypes and POAG in a Swedish population [20]. The lack of association found in the Swedish population may represent a population specific effect, e.g., caused by differences in genetic background between various world populations. The frequency of these genotypes among controls reported here was similar to that reported previously in Saudi Arabs [9] but moderately different from frequencies reported in a Turkish population [17]. These differences may reflect varying ethnic and genetic backgrounds of the populations studied. We were unable to determine whether these polymorphisms were in Hardy-Weinberg equilibrium because heterozygous individuals could not be distinguished from homozygous wild type and because the high consanguinity rate in the Saudi population (>65%) means that the random mating requirement is not satisfied [21]. We did not quantify the interaction between GST genotypes, smoking status, and the development of glaucoma, since only five of our glaucoma patients (4.7%) were smokers.
###end p 42
###begin p 43
###xml 333 334 333 334 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r2">2</xref>
###xml 431 433 431 433 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r22">22</xref>
###xml 434 436 434 436 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r23">23</xref>
###xml 489 491 489 491 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r24">24</xref>
###xml 492 494 492 494 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r25">25</xref>
###xml 580 582 580 582 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r26">26</xref>
###xml 760 765 760 765 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOXL1</italic>
###xml 772 774 772 774 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r27">27</xref>
###xml 871 879 <span type="species:ncbi:9606">patients</span>
Glaucoma is a heterogeneous disease with several important variants that differ at least partially in the apparent mechanisms of optic nerve injury. For example, POAG typically has lower IOP and no obvious ocular changes (in contrast to PEG or PACG) and is suspected of being associated with molecular and biochemical abnormalities [2]. Optic nerve injury in PEG is a component of pseudoexfoliation syndrome, a systemic condition [22,23] that may include stroke and myocardial infarction [24,25], and is frequently associated with severe chronic open-angle glaucoma and cataract [26]. A recent genome-wide screen of Icelandic and Swedish populations detected an association of PEG with two nonsynonymous single nucleotide polymorphisms (SNPs) in exon 1 of the LOXL1 gene [27]. Unfortunately, samples were no longer available for us to test this association among our PEG patients.
###end p 43
###begin p 44
###xml 95 97 95 97 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r28">28</xref>
###xml 114 116 114 116 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r29">29</xref>
###xml 236 238 236 238 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r26">26</xref>
###xml 239 241 239 241 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r29">29</xref>
###xml 242 244 242 244 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r30">30</xref>
###xml 404 406 404 406 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r31">31</xref>
###xml 487 489 487 489 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r32">32</xref>
###xml 610 612 610 612 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r16">16</xref>
###xml 613 615 613 615 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r33">33</xref>
###xml 667 669 667 669 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r34">34</xref>
###xml 736 738 736 738 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r34">34</xref>
###xml 505 510 <span type="species:ncbi:9606">human</span>
PACG has been attributed primarily to elevated IOP caused by anatomic changes in the anterior [28] and posterior [29] globe. However, in each variant, ocular phenomena must interact with the posterior globe to cause optic nerve injury [26,29,30], and recent evidence supports the hypothesis that ROS and oxidative stress may play a contributing role in glaucomatous optic nerve injury at several levels [31]. Oxidative stress may be directly involved in optic nerve neuronal cell death [32]. In addition, human trabecular meshwork (TM) possesses abundant antioxidant activity, and ROS compromise TM integrity [16,33]. Oxidative DNA damage is increased in TM in POAG [34], which might induce degenerative changes favoring increased IOP [34]. Therefore, oxidative stress early in the development and/or throughout life might precipitate both metabolic and anatomic sequelae that increase the risk of optic nerve damage in glaucoma. This may be true even in glaucoma variants that seem primarily anatomic in the mechanism of optic nerve injury such as PACG.
###end p 44
###begin p 45
###xml 224 226 224 226 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r35">35</xref>
###xml 957 959 957 959 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r35">35</xref>
###xml 57 65 <span type="species:ncbi:50278|species:ncbi:153742">quinines</span>
GST enzymes inactivate endogenous unsaturated aldehydes, quinines, epoxides, and hydroperoxides and also protect blood vessels from the effects of endogenous oxidants formed as secondary metabolites during oxidative stress [35]. It is plausible that decreased GST enzyme activity might contribute to inadequate inactivation of these metabolites, exacerbating oxidative stress and increasing the chance of glaucomatous optic nerve injury directly (e.g., in the optic nerve) or remotely (e.g., in the TM and possibly elsewhere in the globe) or both. These effects might be independent of the specific ocular characteristics of the glaucoma syndrome. In fact, the results presented here imply that defects in GST activity may well be risk factors for developing all three variants of glaucoma evaluated. The exact mechanisms by which this occurs are not clear, which is not surprising given that the exact mechanisms of GST activity have yet to be elucidated [35].
###end p 45
###begin p 46
###xml 54 59 54 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTT1</italic>
###xml 64 69 64 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTM1</italic>
In conclusion, this study indicates an association of GSTT1 and GSTM1 polymorphisms to a variable degree with three types of glaucoma. Further investigations are warranted into the precise mechanism by which these genetic polymorphisms may influence the development of glaucoma.
###end p 46
###begin title 47
References
###end title 47
###begin article-title 48
###xml 10 16 <span type="species:ncbi:9606">people</span>
Number of people with glaucoma worldwide.
###end article-title 48
###begin article-title 49
Genetic etiologies of glaucoma.
###end article-title 49
###begin article-title 50
###xml 31 39 <span type="species:ncbi:9606">patients</span>
Mitochondrial abnormalities in patients with primary open-angle glaucoma.
###end article-title 50
###begin article-title 51
Oxidative stress is an early event in hydrostatic pressure induced retinal ganglion cell damage.
###end article-title 51
###begin article-title 52
Oxidative stress in glaucomatous neurodegeneration: mechanisms and consequences.
###end article-title 52
###begin article-title 53
The glutathione S-transferases: an update.
###end article-title 53
###begin article-title 54
Recent advances in the biochemistry and molecular biology of fatty acyl desaturases.
###end article-title 54
###begin article-title 55
T null and M null genotypes of the glutathione S-transferase gene are risk factor for CAD independent of smoking.
###end article-title 55
###begin article-title 56
###xml 53 58 <span type="species:ncbi:9606">human</span>
Glutathione S-transferases genetic polymorphisms and human diseases: overview of epidemiological studies.
###end article-title 56
###begin article-title 57
Glutathione-S-transferase family of enzymes.
###end article-title 57
###begin article-title 58
Frequency of glutathione-S-transferase 1 gene deletion and its possible correlation with cataract formation.
###end article-title 58
###begin article-title 59
Glutathione S-transferase M1, T1, and P1 gene polymorphism in exudative age-related macular degeneration: a preliminary report.
###end article-title 59
###begin article-title 60
May glutathione S-transferase M1 positive genotype afford protection against primary open-angle glaucoma?
###end article-title 60
###begin article-title 61
Polymorphic glutathione S-transferase M1 is a risk factor of primary open-angle glaucoma among Estonians.
###end article-title 61
###begin article-title 62
###xml 63 71 <span type="species:ncbi:9606">patients</span>
Oxidative deoxyribonucleic acid damage in the eyes of glaucoma patients.
###end article-title 62
###begin article-title 63
Glutathione S transferase M1 and T1 genetic polymorphisms are related to the risk of primary open-angle glaucoma: a study in a Turkish population.
###end article-title 63
###begin article-title 64
###xml 47 55 <span type="species:ncbi:9606">Patients</span>
Analysis of Nuclear and Mitochondrial Genes in Patients with Pseudoexfoliation Glaucoma.
###end article-title 64
###begin article-title 65
###xml 38 46 <span type="species:ncbi:9606">Patients</span>
Nuclear and Mitochondrial Analysis of Patients with Primary Angle Closure Glaucoma.
###end article-title 65
###begin article-title 66
Analysis of the Glutathione S-transferase M1 gene using pyrosequencing and multiplex PCR-no evidence of association to glaucoma.
###end article-title 66
###begin article-title 67
Parental responses to consanguinity and genetic disease in Saudi Arabia.
###end article-title 67
###begin article-title 68
Pseudoexfoliation syndrome. Ocular manifestation of a systemic disorder?
###end article-title 68
###begin article-title 69
###xml 56 63 <span type="species:ncbi:9606">patient</span>
Pseudoexfoliative fibrillopathy in visceral organs of a patient with pseudoexfoliation syndrome.
###end article-title 69
###begin article-title 70
Association of pseudoexfoliation syndrome with increased vascular risk.
###end article-title 70
###begin article-title 71
###xml 132 140 <span type="species:ncbi:9606">patients</span>
Generalized transluminance of the iris and the frequency of the pseudoexfoliation syndrome in the eyes of transient ischemic attack patients.
###end article-title 71
###begin article-title 72
Ocular and Systemic Pseudoexfoliation Syndrome.
###end article-title 72
###begin article-title 73
Common Sequence Variants in the LOXL1 Gene Confer Susceptibility to Exfoliation Glaucoma.
###end article-title 73
###begin article-title 74
Possible mechanisms of primary angle-closure and malignant glaucoma.
###end article-title 74
###begin article-title 75
###xml 46 54 <span type="species:ncbi:9606">patients</span>
Sick eye in a sick body: Systemic findings in patients with primary open angle glaucoma.
###end article-title 75
###begin article-title 76
The role of oxidative stress in glaucoma.
###end article-title 76
###begin article-title 77
Optic nerve and neuroprotection strategies.
###end article-title 77
###begin article-title 78
Glaucomatous outflow pathway and oxidative stress.
###end article-title 78
###begin article-title 79
###xml 28 33 <span type="species:ncbi:9606">human</span>
###xml 79 87 <span type="species:ncbi:9606">patients</span>
Oxidative DNA damage in the human trabecular meshwork: clinical correlation in patients with primary open-angle glaucoma.
###end article-title 79
###begin article-title 80
Glutathione transferases.
###end article-title 80

